Global Market Growth Leaders of the Surgical Snare Industry

The global surgical snares market size is expected to grow from USD 992 million in 2018 to USD 1255 million by 2023, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The major driving factors in the surgical snares market are increasing number for colon polypectomy procedures, growth of the endoscopic ASCs segment, and a rising preference for minimally invasive surgeries are the key factors.

The major surgical snares vendors include Olympus (Japan), Boston Scientific (US), Cook Medical (US), CONMED Corporation (US), Medline Industries (US), Medtronic (Ireland), Steris (US), Merit Medical Systems (US), and Avalign Technologies (US). These players have adopted various growth strategies such as acquisitions, new product launches and approval, expansions, to expand their presence in the global surgical snares market. These strategies adopted by major players from 2015 to 2018. This has helped them to innovate their offerings and broaden their customer base.

To know the Insights download the pdf brochure

Olympus Corporation has established its presence in diversified markets; this has helped it to minimize risks and dependency on any particular business segment. The company has a strong product portfolio, which enables it to strengthen its position in the market. It has strong R&D capabilities, which provide it with a strategic advantage over its competitors. The company is focusing on R&D to meet the demands of the surgical snare industry. The company focuses on obtaining market-driven solutions to meet the increasing demand for surgical snare products.

Boston Scientific Corporation focuses on catering to surgical snare market. The company leads in terms of operational and financial strength and has focused on surgical snare market through both organic means. Boston has strong geographic presence in North America and Asia Pacific, which helps company to execute its sales and marketing activities. Company continuously focused on R&D investment, which helps company to expand its product portfolio through new product launches. For instance, in 2015, Boston Scientific launched Captivator EMR Device for endoscopic mucosal resection surgical procedure.

Recent Developments:

• In 2018, Cook Medical launched two new products, Cook Lead Extraction System and Cook Needle’s Eye Snare.
• In 2017, Merit Medical Systems acquired the critical care product portfolio of Argon Medical Devices and Catheter Connections, Inc. This helped Merits to broaden its product offerings and expand geographic presence in the surgical snare market.

Key questions addressed by the report:

• Who are the major market players in surgical snare market?
• What are the regional growth trends and the largest revenue-generating region for surgical snare market?
• What are the major drivers and challenges of the surgical snare market?
• What are the major applications of surgical snare?
• What are the major end user for surgical snare market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Agreement and Collaboration was the Key Growth Strategy in the PEGylated Proteins Market

PEGylated proteins products include consumables and services mainly used for cancer treatment, hepatitis, chronic kidney diseases, haemophilia, multiple sclerosis, and gastrointestinal disorders.

The global PEGylated proteins market was dominated by Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and NOF Corporation (Japan) in 2016. With a broad product portfolio and collaborations and agreements as a key strategy, Merck Millipore held the leadership position in the global PEGylated proteins market in 2016. Merck Millipore signed an agreement with Y-mAbs Therapeutics, Inc. based in New York, U.S. Over the past three years, the company adopted the strategy of agreement & collaboration and acquisition to maintain its leadership position in the global PEGylated proteins market.

Thermo Fisher Scientific, Inc. (U.S.) held the second position in the PEGylated proteins market in 2016. The company has strong geographical presence and mainly focuses on both organic & inorganic strategies such as product upgradation and acquisition to sustain its position in the PEGylated proteins market.

Download the PDF Brochure@ http://bit.ly/2KGH3j0

For instance, in February 2014, Thermo Fisher Scientific, Inc. announced the acquisition of Life Technologies Corporation. Similarly, in August 2014, Thermo Fisher Scientific upgraded its product portfolio by developing new column chemistry called new hydrophobic interaction column used for separating molecules such as monoclonal antibodies, antibody-drug conjugates (ADCs) and proteins.

The other key players in this market include JenKem Technology USA, Inc. (U.S.), Creative PEGworks (U.S), Celares GmbH (Germany), Quanta BioDesign, Ltd. (U.S.), Biomatrik, Inc, (China), Iris Biotech GmbH (Germany), Laysan Bio, Ltd. (U.S.).

The global PEGylated proteins market is highly evolved, with multiple product segments. An analysis of the market developments between 2013 and 2016 revealed that agreement & collaboration and product launch was the most important growth strategy employed by market leaders in this period. This strategy was adopted by all the players in this market.

The other important growth strategy adopted by players in this market is acquisitions and product upgradation. This strategy was adopted by the market players to enhance their product portfolio and geographic presence. These strategies were adopted by major the players in this market such as Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), NOF Corporation (Japan) between 2013 and 2015.

Target audience for this report:

• Academic research institutes
• Pharmaceutical companies
• Biotechnology Companies
• PEGylation products manufacturing companies
• Contract research organizations (CROs)
• Market research & consulting firms

Download TOC: https://www.marketsandmarkets.com/Market-Reports/pegylated-protein-market-19242378.html

Growing Need for Interoperable Solutions Driving Technological Competitiveness in the Global Healthcare IT Solutions Industry

Over the past decade, the global healthcare IT industry has witnessed technological transformation, right from the development of basic EMR/EMR solutions to specialized hospital information management systems, population health management solutions, and healthcare information exchange systems. 

With the growing demand for simplified data sharing among various stakeholders in the healthcare industry, the majority of software vendors are focusing on ensuring interoperability in their product portfolio. Clinical healthcare IT solutions (such as EHR/EMR, CPOE, RIS, and CDSS) and non-clinical solutions (such as healthcare analytics and customer relationship management tools) are at the focus of such innovations from vendors in the healthcare IT market.

The global healthcare IT market is highly fragmented. A majority of small and mid-sized vendors have limited their presence to local or regional markets and are focused on developing specialized healthcare IT solutions. Cerner Corporation (U.S.), GE Healthcare (U.K.), Epic Systems, (U.S.), McKesson Corporation (U.S.), Philips N.V. (Netherlands), and Allscripts Healthcare Solutions, Inc. hold the highest shares in the clinical healthcare IT solutions market. Oracle Corporation (U.S.), Infor, Inc. (U.S.), SAP AG (Germany), and McKesson Corporation (U.S.) are the leaders in the non-clinical healthcare IT market.

Read More Details, Here | Download the PDF Brochure@ http://bit.ly/2BC5hb3

While product innovation remains at the center of the strategic growth initiatives pursued by the majority of key vendors, players are also focusing on increasing their presence in high-growth markets through expansion, marketing and distribution agreements, and acquisition. Currently, market players are focusing on expansion in the Asia-Pacific region.

Cerner Corporation’s leading position in the clinical solutions market is mainly attributed to its broad product portfolio and major focus on clinical healthcare IT solutions. While nearly 89% of the company’s revenue is generated from operations in the North American market, currently, the company is focusing on strengthening its presence in international markets as well. For instance, in February 2015, Cerner Corporation acquired Siemens’s health information technology business unit for ~USD 1.3 billion; this strengthened its client base in the global market and reach in European countries such as Germany, Austria, Spain, Sweden, and Norway.

McKesson Corporation offers a wide range of both clinical and non-clinical healthcare IT solutions; this has enabled the company to achieve a leading position in the global healthcare IT market. The company generates a majority of its revenue from North American operations. EPIC Systems (U.S.) and Allscripts Healthcare Solutions, Inc. are leading providers of EHR systems and related solutions in the U.S.

Other prominent players in the market include GE Healthcare (U.K.), Siemens Healthcare (Germany), and Philips Healthcare (Netherlands). These companies have strong global footprints, owing to their well-established sales and distribution networks. They also make significant investments in R&D activities to add innovative technologies and products to their portfolio. With their strong portfolios and efforts to develop innovative products, these companies are likely to maintain their leadership in the market in the coming years as well.

Still Searching for More Detailed information? | Feel Free to Talk to Our Research Experts, Here..!

Primary Research:

The healthcare IT solutions market comprises several stakeholders such as Healthcare IT solution providers healthcare IT vendors, healthcare IT service providers, healthcare payers, academic research institutes, government institutes, market research & consulting firms and venture capitalists & investors. Primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, and innovation directors of healthcare IT integration solutions companies. Demand-side primary sources include industry experts such as healthcare providers from hospitals and clinics and healthcare payers.

Secondary Research:

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, trade directories, and databases such as D&B Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.

Hepatitis Test Solution Market - Factors Considered by the Major Players for Their Global Growth

The global hepatitis test solution/diagnosis market is estimated to account for USD 2.66 billion in 2018 and is projected to reach USD 3.37 billion by 2023, at a CAGR of 4.9%.

Initiatives taken by government and non-government organizations, high burden of hepatitis worldwide, increasing number of blood transfusions & donations, and benefits offered by point of care instruments & kits are the major factors driving this market.

Restraints:
# High Cost of Nat
# Lack of Mandate for Nat in Developing Countries

Opportunities:
# Emerging Markets



To know the Insights download the pdf brochure

Collaborations, agreements, and partnerships remain at the center of the strategic growth initiatives adopted by most of the key players in the global hepatitis test solution/diagnosis market. Companies such as Abbott Laboratories, Roche Diagnostics, Bio-Rad, DiaSorin, Danaher, and Grifols have been focusing on this inorganic strategy to enhance their market presence. Players also adopted product launches, product approval, and acquisition as growth strategies.

Roche Diagnostics was the largest player in the hepatitis testing market. The company offers a wide range of test kits and systems. The firm mainly focuses on R&D investment and product launches & approvals. In 2017, the company invested ~13% of its total revenue in R&D to develop new product offerings. Geographically, the company operates in different countries across North America, Latin America, Europe, the Middle East, Africa, and Asia. Roche also focuses on collaborations to enhance its market presence.

Abbott Laboratories is an important player in the global hepatitis testing market. The company offers a wide range of products, including assays & reagents, systems, and informatics solutions & services. Abbott focuses on strengthening its position in the market by adopting organic strategies, such as collaborations, agreements, partnerships, and acquisitions. In 2018, the company entered into partnerships with pathology and research centers to expand its geographical presence across the globe.

You Can Also Talk to Our Research Experts for More Details@ http://bit.ly/2DLsMQt

Some other leading players in the global hepatitis test solution/diagnosis market include Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), Danaher (US), bioMérieux (France), and Grifols (Spain). These companies have well-established sales and distribution networks across the globe. They also make significant investments in R&D activities to develop innovative technologies and products. Focus on innovation plays an important role in this market.

Target Audience:

• Blood banks
• Pathologists and pathology laboratories
• Distributors of IVD products
• Research institutes
• Hospitals and clinics
• Healthcare institutions
• Group purchasing organizations (GPOs)
• Market research and consulting firms

Dental Lab Market - Emerging Trends & Global Growth Boosting Factors

The global dental lab market is projected to reach USD 43.08 Billion by 2022 from USD 32.56 Billion in 2017, growing at a CAGR of 5.8% during the forecast period.

A number of factors such as rapid growth in the geriatric population and the associated increase in the prevalence of edentulism, growing dental tourism in emerging markets, rising incidence of dental caries and other periodontal diseases, and the increased outsourcing of customization and fabrication of restorative and prosthetic products to dental laboratories are driving the market growth for dental laboratories.

However, the high cost of dental materials and equipment is the major factor expected to restrain the growth of the dental laboratory market during the forecast period.

Download the PDF Brochure for More Details@ http://bit.ly/2SatCKD

The report analyzes the global dental laboratory market by material, equipment, prosthetic type, and region. Based on indirect restorative material, the global market is segmented into metal ceramics, ceramics, and other indirect restorative materials, such as cast-gold (high noble) alloys and base metal (non-noble) alloys.

In 2016, the metal ceramics segment accounted for the largest share of global dental laboratories market mainly due to its strength, durability, resistance to fracture, and high biocompatibility as compared to ceramics and other indirect restorative materials.
Based on equipment, the global dental laboratory market is segmented into articulators, furnaces, scanners, and milling equipment. The milling equipment segment accounted for the largest share of the global dental laboratory market in 2016. The scanners segment is expected to grow at the highest CAGR during the forecast period. The rising focus on digital dental products, increasing efforts towards delivering faster dental treatment, increased development and penetration of computer-aided drawing, and computer-aided manufacturing in dentistry are expected to drive the uptake of dental scanners.
On the basis of prosthetic type, the dental lab market is segmented into crowns, dentures and bridges. In 2016, the crowns segment dominated the market. The large share of this segment is mainly attributed to the large number of single tooth implant restoration procedures.

Geographically, the global dental lab market is segmented into North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. Europe holds the largest share of this market. However, the APAC region is expected to witness the highest CAGR during the forecast period of 2017 to 2022.

The growth of this segment can be attributed to the rising geriatric population, growing dental tourism, increase in the number of dental laboratories, and increasing outsourcing of various manufacturing services to the region are driving the growth of dental laboratories in APAC. However, the high cost of the dental equipment and materials is expected to hinder the growth of this market to a certain extent.

The global dental laboratory market is characterized by a large number of players. The prominent players in this market are DENTSPLY SIRONA Inc. (U.S.), Danaher Corporation (U.S.), 3M Company (U.S.), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Planmeca Group (Finland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), Shofu Inc. (Japan), BEGO GmbH & Co. KG (Germany), VOCO GmbH (Germany), Ultradent Products, Inc. (U.S.), Septodont Holding (France), Planmeca Oy (Finland), and Kuraray Noritake Dental Inc. (Japan). These companies are pursuing several organic and inorganic growth strategies such as mergers, acquisitions, partnerships, agreements, expansions, and product launches to maintain their position in the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Surgical Snare Market: Major Industry Leaders & Their Global Growth Story

The global surgical snares market size is expected to grow from USD 992 million in 2018 to USD 1255 million by 2023, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. 

The major driving factors in the surgical snares market are increasing number for colon polypectomy procedures, growth of the endoscopic ASCs segment, and a rising preference for minimally invasive surgeries are the key factors.

To know the Insights download the pdf brochure@ http://bit.ly/2zBWG6b

These players have adopted various growth strategies such as acquisitions, new product launches and approval, expansions, to expand their presence in the global surgical snares market. These strategies adopted by major players from 2015 to 2018. This has helped them to innovate their offerings and broaden their customer base.

Olympus Corporation has established its presence in diversified markets; this has helped it to minimize risks and dependency on any particular business segment. The company has a strong product portfolio, which enables it to strengthen its position in the market. It has strong R&D capabilities, which provide it with a strategic advantage over its competitors. The company is focusing on R&D to meet the demands of the surgical snare industry. The company focuses on obtaining market-driven solutions to meet the increasing demand for surgical snare products.

Boston Scientific Corporation focuses on catering to surgical snare market. The company leads in terms of operational and financial strength and has focused on surgical snare market through both organic means. Boston has strong geographic presence in North America and Asia Pacific, which helps company to execute its sales and marketing activities. Company continuously focused on R&D investment, which helps company to expand its product portfolio through new product launches. For instance, in 2015, Boston Scientific launched Captivator EMR Device for endoscopic mucosal resection surgical procedure.

Recent Developments:

# In 2018, Cook Medical launched two new products, Cook Lead Extraction System and Cook Needle’s Eye Snare.

# In 2017, Merit Medical Systems acquired the critical care product portfolio of Argon Medical Devices and Catheter Connections, Inc. This helped Merits to broaden its product offerings and expand geographic presence in the surgical snare market.

Key questions addressed by the report:

# Who are the major market players in surgical snare market?

# What are the regional growth trends and the largest revenue-generating region for surgical snare market?

# What are the major drivers and challenges of the surgical snare market?

# What are the major applications of surgical snare?

# What are the major end user for surgical snare market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst@ http://bit.ly/2qC07Wj

Burning Issue: Increasing Awareness About the Growing Industrial Applications of Viscometers and Rheometers Among End Users

The report studies the global Rheometers and Viscometers Market over the forecast period from 2018 to 2023. The market is projected to reach USD 878.6 million by 2023 from USD 721.5 million in 2018, at a CAGR of 4.0%.

The demand for rheometers and viscometers across key markets is majorly driven by factors such as technology advancements; expansion of petrochemical and material manufacturing industries; growing stringency of the regulatory framework for product safety compliance in cosmeceutical, biotechnology, and pharmaceutical industries; rising public-private investments to support product innovation; and increasing burden of target diseases, globally. However, the high cost of viscometers and rheometers is expected to restrain the growth of this market during the forecast period.

Download the PDF Brochure for More Details@ http://bit.ly/2QwjvPU

Based on product, viscometers are estimated to account for the largest share of the rheometers and viscometers market in 2018.

On the basis of product, the rheometers and viscometers market is segmented into rheometers (further segmented into dynamic rotational rheometers, torque rotational rheometers, capillary rheometers, oscillatory rheometers, high-throughput rheometers, and other rheometers) and viscometers (further segmented into rotational viscometers, process viscometers, capillary viscometers, and other viscometers). The viscometers segment is expected to account for the largest share of the global rheometers and viscometers market in 2018. 

The large share of this segment can be attributed to the increasing adoption of viscometers among lab technicians and researchers in pharmaceutical and petrochemical industries due to the procedural benefits offered by these instruments, such as the capability to analyze samples in varied environments, high accuracy, versatility for analyzing different samples, ease of handling, fast processing time, device portability, need of small sample volume, capability to analyze time-dependent fluids, and capability to perform shear-dependent analysis at various speeds.

Based on end user, the petroleum product manufacturers & petrochemical refineries segment is expected to account for the largest share of this market in 2018.

On the basis of end user, the rheometers and viscometers market is categorized into petroleum product manufacturers & petrochemical refineries; pharmaceutical, cosmeceutical, and biotechnology companies; chemical and material manufacturers; food and beverage manufacturers; research laboratories and academic institutes, and other end users. Petroleum product manufacturers & petrochemical refineries are expected to account for the largest share of the rheometers and viscometers market in 2018. The mandatory rheological evaluations for product quality assessment as regulatory guidelines across respective countries and the rising production output & capabilities of major product manufacturers are the key factors supporting the growth of the rheometers and viscometers market for petroleum product manufacturers & petrochemical refineries.

You Can Also Ask for the Customized Information As Per Your Requirements@ http://bit.ly/2AVz9yR

North America is expected to dominate the rheometers and viscometers market in 2018.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The large share of North America can be attributed to ongoing technological advancements in the field of rheometers & viscometers, the wide availability of rheometers and viscometers in the region (owing to the strong distribution networks of major product manufacturers in North America), and the strong presence of major device manufacturers.

Major players operating in the market include Anton Paar (Austria), Spectris (UK), Waters Corporation (US), Brookfield Engineering Laboratories (US), Cannon Instruments Company (US), Thermo Fisher Scientific (US), Emerson (US), BARTEC (Germany), GBC Scientific Equipment (Australia), Dynisco Polymer Test (US), Lamy Rheology Instruments (France), GOTTFERT (Germany), Hydramotion (US), and PAC LP (US), among others.